arrow
M

Michał Tendera

Medical University of Silesia
H指数:104
被引数:18.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Smoking trajectories and residual cardiovascular risk in patients with stable coronary artery disease: an international cohort study

吸烟轨迹和稳定型冠状动脉疾病患者中的残余心血管风险:一项国际队列研究

2025-05-013
PRE
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
2024-05-0226
PRE
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

心内膜心肌活检: 欧洲心脏病学会EURObservational研究计划心肌病和心肌炎长期注册表中儿童和成人心肌炎的安全性和预后效用

2024-04-104
OA
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

儿童和青少年的心肌病: 欧洲心脏病学会EURObservational研究计划心肌病和心肌炎注册表的病因,管理和结果

2024-03-015
OAAI
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
2022-11-24318
OA
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocardits Registry
2021-01-0812
OAAI
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
2021-01-0170
OAAI
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
2020-11-1128
OAAI